Javascript must be enabled to continue!
Tasty THC: Promises and Challenges of Cannabis Edibles
View through CrossRef
Food products containing cannabis extract (edibles) have emerged as a popular and lucrative facet of the legalized market for both recreational and medicinal cannabis. The many formulations of cannabis extracts used in edibles present a unique regulatory challenge for policy makers. Though edibles are often considered a safe, discreet, and effective means of attaining the therapeutic and/or intoxicating effects of cannabis without exposure to the potentially harmful risks of cannabis smoking, little research has evaluated how ingestion differs from other methods of cannabis administration in terms of therapeutic efficacy, subjective effects, and safety. The most prominent difference between ingestion and inhalation of cannabis extracts is the delayed onset of drug effect with ingestion. Consumers often do not understand this aspect of edible use and may consume a greater than intended amount of drug before the drug has taken effect, often resulting in profoundly adverse effects. Written for the educated layperson and for policy makers, this paper explores the current state of research regarding edibles, highlighting the promises and challenges that edibles present to both users and policy makers, and describes the approaches that four states in which recreational cannabis use is legal have taken regarding regulating edibles.
Title: Tasty THC: Promises and Challenges of Cannabis Edibles
Description:
Food products containing cannabis extract (edibles) have emerged as a popular and lucrative facet of the legalized market for both recreational and medicinal cannabis.
The many formulations of cannabis extracts used in edibles present a unique regulatory challenge for policy makers.
Though edibles are often considered a safe, discreet, and effective means of attaining the therapeutic and/or intoxicating effects of cannabis without exposure to the potentially harmful risks of cannabis smoking, little research has evaluated how ingestion differs from other methods of cannabis administration in terms of therapeutic efficacy, subjective effects, and safety.
The most prominent difference between ingestion and inhalation of cannabis extracts is the delayed onset of drug effect with ingestion.
Consumers often do not understand this aspect of edible use and may consume a greater than intended amount of drug before the drug has taken effect, often resulting in profoundly adverse effects.
Written for the educated layperson and for policy makers, this paper explores the current state of research regarding edibles, highlighting the promises and challenges that edibles present to both users and policy makers, and describes the approaches that four states in which recreational cannabis use is legal have taken regarding regulating edibles.
Related Results
Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC
Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC
AbstractBackground: Δ9-Tetrahydrocannabinol (THC) is the primary psychoactive constituent of cannabis and an active cannabinoid pharmacotherapy component. No plasma pharmacokinetic...
Delta-8-THC: Delta-9-THC’s nicer younger sibling?
Delta-8-THC: Delta-9-THC’s nicer younger sibling?
Abstract
Background
Products containing delta-8-THC became widely available in most of the USA following the 2018 Farm Bill and by late 2020 were co...
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain
Objectives. To update the evidence on benefits and harms of cannabinoids and other plant-based compounds to treat subacute and chronic pain in adults and adolescents using a living...
A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)
A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)
Cannabis sativa contains numerous cannabinoids, with D9-tetrahydrocannabinol (THC) and cannabidiol (CBD) the primary cannabinoids of medical interest. Both THC and CBD possess pote...
Disparities in use modalities among adults who currently use cannabis, 2022-2023
Disparities in use modalities among adults who currently use cannabis, 2022-2023
Abstract
Purpose: Following the legalization of cannabis in several U.S. states, the cannabis market has expanded, leading to a wider range of products including smoked, ed...
The Influence of Exports, Imports, Foreign Direct Investment, and Exchange Rates on Indonesia's Current Account Balance 2010 – 2022
The Influence of Exports, Imports, Foreign Direct Investment, and Exchange Rates on Indonesia's Current Account Balance 2010 – 2022
Thc current account, akey compoment of thc balance of payments, includes thc trade balance, services, investment income, unilateral transactions, ard grants, all of which indicate ...
Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users
Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users
Background:
Recently increased access to cannabis products in the United States has been associated with increased rates of driving after cannabis use. Although...
Impact de deux phytocannabinoïdes, le Delta-9-Tétrahydrocannabinol et le CBD, utilisés à des fins récréatives et thérapeutiques, sur la physiologie du testicule
Impact de deux phytocannabinoïdes, le Delta-9-Tétrahydrocannabinol et le CBD, utilisés à des fins récréatives et thérapeutiques, sur la physiologie du testicule
Aujourd’hui, les débats s’intensifient dans le monde pour la légalisation du cannabis à usage récréationnel ou thérapeutique. Un risque accru de développer des tumeurs testiculaire...

